Evosep is at the forefront of innovation in clinical proteomics, primarily through its flagship technology, the Evosep One. This advanced liquid chromatography platform is designed to enhance the speed and robustness of protein analysis, making it particularly suitable for clinical applications. The Evosep One integrates automated sample preparation with user-friendly workflows, allowing researchers to conduct high-sensitivity proteomic analyses even with limited sample volumes. The system is capable of processing a wide range of samples efficiently, with methods that can analyze anywhere from 30 to 500 samples per day, thereby significantly improving throughput in clinical settings.

Central to the Evosep One's functionality are the Evotips, disposable trap columns that streamline sample loading and minimize carry-over, contributing to the platform's overall efficiency and reliability. This technology not only simplifies the workflow but also ensures high data quality, which is crucial for clinical diagnostics. By focusing on standardization and automation, Evosep aims to make liquid chromatography mass spectrometry (LCMS) accessible and effective for routine clinical use, ultimately enhancing patient care and advancing the field of clinical research.

Denmark

Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster.

We are targeting the growing need for throughput with robust solutions for clinical and large-scale proteomics, and we have a very ambitious business plan to bring the community closer to the clinic.
 
We are basing our design on years of experience with nano-UHPLC R&D and application support, critically rethinking the necessary system architectures for successful sample separation before mass spectrometric analysis.

Evosep

Company Details